Xtandi 40 MG capsule 120S

Ended Awarded

Contract number
SPE2DX24F94Y1
Awardee
Awarding agency
Obligated
$8,623

Award facts

Contract value 100% obligated
$8,622.72 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the firm's existing indefinite delivery contract SPE2DB with the Defense Logistics Agency (DLA). The $8,622.72 firm fixed-price order is for the supply of XTANDI 40 MG CAPSULE 120S to support the medical supply needs of military health facilities. This contract has no set-aside designation. The DLA SPE2DB contract, valued up to $4,999,999 through 2025, enables the agency to issue delivery orders for a broad range of pharmaceutical products to fulfill the recurring requirements of the Department of Defense medical system.

Quick answers

Who was awarded contract SPE2DX24F94Y1?

SPE2DX24F94Y1 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on March 14, 2024.

How much is contract SPE2DX24F94Y1 worth?

The government has obligated $8,623 on SPE2DX24F94Y1.

Is contract SPE2DX24F94Y1 an order under another contract?

Yes. SPE2DX24F94Y1 is a delivery order under SPE2DX15D9144, an indefinite delivery contract.

Was contract SPE2DX24F94Y1 competed?

The extent of competition for SPE2DX24F94Y1 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award